613 related articles for article (PubMed ID: 34359993)
1. Fibrosis, the Bad Actor in Cardiorenal Syndromes: Mechanisms Involved.
Delgado-Valero B; Cachofeiro V; Martínez-Martínez E
Cells; 2021 Jul; 10(7):. PubMed ID: 34359993
[TBL] [Abstract][Full Text] [Related]
2. Cardiorenal Syndrome Revisited.
Zannad F; Rossignol P
Circulation; 2018 Aug; 138(9):929-944. PubMed ID: 30354446
[TBL] [Abstract][Full Text] [Related]
3. Cardiorenal Syndrome: An Overview.
Ronco C; Bellasi A; Di Lullo L
Adv Chronic Kidney Dis; 2018 Sep; 25(5):382-390. PubMed ID: 30309455
[TBL] [Abstract][Full Text] [Related]
4. Renal fibrosis in type 2 cardiorenal syndrome: An update on mechanisms and therapeutic opportunities.
Xu X; Zhang B; Wang Y; Shi S; Lv J; Fu Z; Gao X; Li Y; Wu H; Song Q
Biomed Pharmacother; 2023 Aug; 164():114901. PubMed ID: 37224755
[TBL] [Abstract][Full Text] [Related]
5. Cardiac and renal fibrosis in chronic cardiorenal syndromes.
Hundae A; McCullough PA
Nephron Clin Pract; 2014; 127(1-4):106-12. PubMed ID: 25343831
[TBL] [Abstract][Full Text] [Related]
6. Heart functional and structural compendium of cardiosplenic and cardiorenal networks in acute and chronic heart failure pathology.
Halade GV; Kain V; Ingle KA
Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H255-H267. PubMed ID: 29101178
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of Cardiorenal Syndrome.
Uduman J
Adv Chronic Kidney Dis; 2018 Sep; 25(5):391-399. PubMed ID: 30309456
[TBL] [Abstract][Full Text] [Related]
8. Cellular apoptosis in the cardiorenal axis.
Virzì GM; Clementi A; Ronco C
Heart Fail Rev; 2016 Mar; 21(2):177-89. PubMed ID: 26852141
[TBL] [Abstract][Full Text] [Related]
9. Target organ cross talk in cardiorenal syndrome: animal models.
Bongartz LG; Braam B; Gaillard CA; Cramer MJ; Goldschmeding R; Verhaar MC; Doevendans PA; Joles JA
Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1253-63. PubMed ID: 22914779
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of chronic cardiorenal syndrome: is there a role for oxidative stress?
Rubattu S; Mennuni S; Testa M; Mennuni M; Pierelli G; Pagliaro B; Gabriele E; Coluccia R; Autore C; Volpe M
Int J Mol Sci; 2013 Nov; 14(11):23011-32. PubMed ID: 24264044
[TBL] [Abstract][Full Text] [Related]
11. [Organ damage and cardiorenal syndrome in acute heart failure].
Casado Cerrada J; Pérez Calvo JI
Med Clin (Barc); 2014 Mar; 142 Suppl 1():26-31. PubMed ID: 24930080
[TBL] [Abstract][Full Text] [Related]
12. [PATHOPHYSIOLOGY OF THE CARDIORENAL SYNDROME].
Balint I; Vučak J; Bašić-Marković N; Klarić D; Šakić VA
Acta Med Croatica; 2016 Dec; 70(4-5):325-31. PubMed ID: 29087629
[TBL] [Abstract][Full Text] [Related]
13. The guanylate cyclase C agonist linaclotide ameliorates the gut-cardio-renal axis in an adenine-induced mouse model of chronic kidney disease.
Nanto-Hara F; Kanemitsu Y; Fukuda S; Kikuchi K; Asaji K; Saigusa D; Iwasaki T; Ho HJ; Mishima E; Suzuki T; Suzuki C; Tsukimi T; Matsuhashi T; Oikawa Y; Akiyama Y; Kure S; Owada Y; Tomioka Y; Soga T; Ito S; Abe T
Nephrol Dial Transplant; 2020 Feb; 35(2):250-264. PubMed ID: 31411705
[TBL] [Abstract][Full Text] [Related]
14. Cardiorenal Syndrome: Pathophysiology.
Kumar U; Wettersten N; Garimella PS
Cardiol Clin; 2019 Aug; 37(3):251-265. PubMed ID: 31279419
[TBL] [Abstract][Full Text] [Related]
15. Cardiorenal syndrome: pathophysiological mechanism, preclinical models, novel contributors and potential therapies.
Fu Q; Cao L; Li H; Wang B; Li Z
Chin Med J (Engl); 2014; 127(16):3011-8. PubMed ID: 25131243
[TBL] [Abstract][Full Text] [Related]
16. Apocynin Attenuates Cardiac Injury in Type 4 Cardiorenal Syndrome via Suppressing Cardiac Fibroblast Growth Factor-2 With Oxidative Stress Inhibition.
Liu Y; Liu Y; Liu X; Chen J; Zhang K; Huang F; Wang JF; Tang W; Huang H
J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26109504
[TBL] [Abstract][Full Text] [Related]
17. Proteomic Biomarkers in the Cardiorenal Syndrome: Toward Deciphering Molecular Pathophysiology.
He T; Zhang Z; Staessen JA; Mischak H; Latosinska A; Beige J
Am J Hypertens; 2021 Aug; 34(7):669-679. PubMed ID: 33821948
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of cardiorenal syndrome in patients with heart failure: potential therapeutic targets.
Takahama H; Kitakaze M
Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H715-H721. PubMed ID: 28733448
[TBL] [Abstract][Full Text] [Related]
19. RAAS inhibition and cardiorenal syndrome.
Onuigbo MA
Curr Hypertens Rev; 2014; 10(2):107-11. PubMed ID: 25549841
[TBL] [Abstract][Full Text] [Related]
20. Subtotal nephrectomy accelerates pathological cardiac remodeling post-myocardial infarction: implications for cardiorenal syndrome.
Liu S; Kompa AR; Kumfu S; Nishijima F; Kelly DJ; Krum H; Wang BH
Int J Cardiol; 2013 Oct; 168(3):1866-80. PubMed ID: 23347614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
